Insights From The Association Of British Clinical Diabetologists

K. Su Khin^1,2, T. Crabtree^1,2, A. L. Liarakos^1,2, V. Oguntolu³, A. Gough³, G. R. Mudiyanselage³, K. A. Adamson⁴, E. G. Wilmot^1,2, I. Idris ^1,2, R. E. J. Ryder⁵

REJ RYDER¹, A ESCALONA², R LOPEZ-GONZALEZ³, C LAZZARA³, J PUJOL-GEBELLI³, J STEIN⁴, T BATTELINO⁵, JP TEARE⁶, A RUBAN⁶, M HALUZIK⁷, L MUNRO⁸, H FRYDENBERG⁸, JJ.

ABCD and UK Kidney Association (UKKA) Diabetic Kidney Disease Clinical Speciality Group have previously undertaken a narrative review and critical appraisal of the available evidence to inform clinical practice guidelines for the pharmacological management of hyperglycemia in adults with T2DM and CKD.

Thursday 11th September 2025, 17:00 - 18:00

Join the Diabetes Technology Network UK (DTN-UK) for a discussion of the current state of hybrid closed loop (HCL) rollout and any issues arising from this.

Together we will explore: